Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Author Correction: 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis.

Nature·2026

Same author

Caspase-3/7 deficiency results in enhanced intestinal inflammation and reduced tumorigenesis.

Science advances·2026

Same author

Riboflavin metabolism shapes FSP1-driven ferroptosis resistance.

Nature cell biology·2026

Same author

Fat bolsters tumours against ferroptosis.

Nature cell biology·2026

Same author

Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression.

Science advances·2026

Same author

Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice.

Science translational medicine·2025

Same journal

Systemic health impact of cancer-associated extracellular vesicles and particles.

Nature reviews. Cancer·2026

Same journal

Imaging the hallmarks of cancer.

Nature reviews. Cancer·2026

Same journal

CLIM-TIME links tumour genetics to spatial immune architecture.

Nature reviews. Cancer·2026

Same journal

Serving sulfur to boost anti-tumour immunity.

Nature reviews. Cancer·2026

Same journal

How to give a bad talk.

Nature reviews. Cancer·2026

Same journal

Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity.

Nature reviews. Cancer·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 15, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

Decoding ferroptosis for cancer therapy.

Adam Wahida^1,2,3, Marcus Conrad^4,5

¹Institute of Metabolism and Cell Death, Helmholtz Munich, Neuherberg, Germany.

Nature Reviews. Cancer

|October 10, 2025

Summary

This summary is machine-generated.

Cancer cells resist death through mechanisms like ferroptosis, an iron-dependent process. This review explores targeting ferroptosis for cancer therapy, discussing its biology, therapeutic strategies, and clinical translation challenges.

More Related Videos

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Related Experiment Videos

Last Updated: Jan 15, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

Area of Science:

Biochemistry
Cancer Biology
Oncology

Background:

Cancer cells acquire traits to resist cell death, including ferroptosis suppression.
Ferroptosis, a form of regulated cell death, is iron-dependent lipid peroxidation.
Understanding ferroptosis is crucial as its deregulation intersects with cancer hallmarks.

Purpose of the Study:

To review the biochemical basis of ferroptosis.
To examine the role of ferroptosis in cancer biology.
To explore strategies for targeting ferroptosis in cancer therapy.

Main Methods:

Literature review of ferroptosis research.
Analysis of biochemical pathways involved in ferroptosis.
Discussion of therapeutic strategies and clinical considerations.

Main Results:

Ferroptosis is a distinct regulated cell death pathway suppressed by cancer cells.
Targeting ferroptosis presents a potential therapeutic strategy for malignancies.
Further research is needed to overcome challenges in clinical translation.

Conclusions:

Ferroptosis is a promising but complex target in cancer therapy.
Addressing therapeutic windows and biomarkers is essential for clinical application.
Ferroptosis's role in cancer immunogenicity and redox balance warrants further investigation.